We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Guy Rouleau MD, PhD

Guy Rouleau MD, PhD

Director, Montreal Neurological Institute-Hospital, McGill University, Montréal, Québec, Canada

Dr. Guy Rouleau is Director of The Neuro (Montreal Neurological Institute‐Hospital), Chair of the Department of Neurology and Neurosurgery of McGill University, Director of the Department of Neuroscience of McGill University Health Centre, and co‐founder of the Tanenbaum Open Science Institute. He was recently elected Vice‐President of the World Federation of Neurology.

For more than 30 years, Dr. Guy Rouleau and his team have focused on identifying the genes causing several neurological and psychiatric diseases, including autism, amyotrophic lateral sclerosis, hereditary neuropathies, epilepsy and schizophrenia, as well as providing a better understanding of the molecular mechanisms that lead to these disease symptoms. Among Dr. Rouleau’s main achievements are his contribution to the identification of dozens of diseasecausing genes and his discovery of new mutational mechanisms.

Dr. Rouleau has published over 900 articles in peer‐reviewed journals and has been quoted more than 95 000 times (Google Scholar). He has supervised more than a hundred students at the Masters, PhD and Post‐doctoral levels in addition to receiving numerous awards for his contribution to science and society.

As co‐founder of the Tanenbaum Open Science Institute, Dr. Rouleau is pioneering a new way of doing research by transforming The Neuro into the first academic institution to adopt Open Science principles in order to accelerate discovery and benefit patients and society.